U.S., April 30 -- ClinicalTrials.gov registry received information related to the study (NCT06949956) titled 'Administration of Fingolimod in Greek Patients With Multiple Sclerosis.' on April 28.
Brief Summary: The goal of this observational study is to evaluate the efficacy of fingolimod through the estimation of the annualized relapse rate (ARR) over a period of 2 years.
Participants who are already taking fingolimod as part of their regular medical care for MS will answer questions about their medical history for the past 1 year and for their status for the next 2 years.
Study Start Date: June 01
Study Type: OBSERVATIONAL
Condition:
Relapsing Remitting Multiple Sclerosis
Recruitment Status: NOT_YET_RECRUITING
Sponsor: Elpen Pharm...